Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast

Modern Pathology

Volumn 18, Issue 10, 2005, Pages 1277-1282

  Mastropasqua, Mauro G ^a   Maiorano, Eugenio ^b   Pruneri, Giancarlo ^a   Orvieto, Enrico ^c   Mazzarol, Giovanni ^a   Vento, Anna R ^d   Viale, Giuseppe ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^c Regional Hospital   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Adenoid cystic carcinoma; Breast; c kit; p63

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P63; STEM CELL FACTOR RECEPTOR; UVOMORULIN;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER INFILTRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LABELING INDEX; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CARCINOMA, ADENOID CYSTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 25144521915     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800423     Document Type: Article

References (29)

1. Rosen PP. Adenoid cystic carcinoma. In: Rosen PP (ed). Rosen's Breast Pathology 2nd edn. Lippincott Williams & Wilkins: Philadelphia, PA, 2001, pp 535-549.
2. Tavassoli F. Infiltrating carcinoma, special types. In: Tavassoli F (ed). Pathology of the Breast. Appleton & Lange: Stamford, 1992, pp 403-414.
3. Ellis IO. Adenoid cystic carcinoma. In: Tavassoli F, Devilee P (eds). Tumours of the Breast and Female Genital Organs. Pathology & Genetics. IARC Press: Lyon, 2003, pp 44-45.
4. Azumi N, Battifora H. The cellular composition of adenoid cystic carcinoma. An immunohistochemical study. Cancer 1987;60:1589-1598.
5. Kasami M, Olson SJ, Simpson JF, et al. Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: an immunohistochemical study. Histopathology 1998;32:232-238.
6. Shin S, Rosen PP. Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases. Am J Surg Pathol 2002;26:413-420.
7. Page DL. Special types of invasive breast cancer, with clinical implications. Am J Surg Pathol 2003;27:832-835.
8. Herzberg AJ, Bossen EH, Walter PJ. Adenoid cystic carcinoma of the breast metastatic to the kidney. A clinically symptomatic lesion requiring surgical management. Cancer 1991;68:1015-1020.
9. Arpino G, Clark GM, Mohsin S, et al. Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer 2000;94:2119-2127.
10. Duan GJ, Liu FX, Yan XC, et al. Clinical significance of E-Cadherin and proliferating cell nuclear antigen expression in adenoid cystic carcinoma [abstract]. Ai Zheng 2002;21:522-525.
11. McClenathan JH, de la Roza G. Adenoid cystic breast cancer. Am J Surg 2002;183:646-649.
12. Foschini MP, Reis Filho JS, Eusebi V, et al. Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol 2003;56:497-506.
13. Fukuoka K, Hirokawa M, Shimizu M, et al. Basaloid type adenoid cystic carcinoma of the breast. APMIS 1999;107:762-766.
14. Kontos M, Fentiman IS. Adenoid cystic carcinoma of the breast. Int J Clin Pract 2003;57:669-672.
15. Kleer CG, Oberman HA. Adenoid cystic carcinoma of the breast: value of the histologic grading and proliferative activity. Am J Surg Pathol 1998;22:569-575.
16. Trendell-Smith NJ, Peston D, Shousha S. Adenoid cystic carcinoma of the breast, a tumor commonly devoid of estrogen receptor and related proteins. Histopathology 1999;35:241-248.
17. Holst VA, Marshall CE, Moskaluk CA, et al. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 1999;12:956-960.
18. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-1060.
19. Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol 2003;16:1224-1231.
20. Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:613-619.
21. Emanuel P, Wang B, Wu M, et al. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol advance online publication 29 October 2004.
22. Jill P. c-kit expression in adenoid cystic carcinoma of the breast. Pathology 2004;36:362.
23. Crisi GM, Marconi SA, Magari-Judson G, et al. Expression of c-kit in adenoid cystic carcinoma of the breast. Mod Pathol 2004;17(Suppl1):27A (abstract).
24. Matte C, Visscher DW, Reynolds C. c-kit protein expression in adenoid cystic carcinoma of the breast. Mod Pathol 2004;17(Suppl1):41A (abstract).
25. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-185.
26. Franchi A, Gallo O, Bocciolini C, et al. Reduced E-cadherin expression correlates with unfavorable prognosis in adenoid cystic carcinoma of salivary glands of the oral cavity. Am J Clin Pathol 1999;111:43-50.
27. Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol 1987;18:1276-1281.
28. Sobin LH, Wittekind C (eds). TNM Classification of Malignant Tumours. 6th edn. Wiley-Liss: New York, 2002.
29. Lamovec J, Us-Krasovec M, Zidar A, et al. Adenoid cystic carcinoma of the breast: a histologic, cytologic and immunohistochemical study. Semin Diagn Pathol 1989;6:153-164.